Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| IGC Pharma, Inc. |
| MEXER◆ |
| 16,667 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Apr 1 | IGC | IGC Pharma, Inc. | MEXER◆ | 323,077 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | IGC | IGC Pharma, Inc. | MEXER◆ | 333,333 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | IGC | IGC Pharma, Inc. | MEXER | 33,332 | — | — | +3.8% | Open the original filing on SEC.gov |
| Apr 1 | IGC | IGC Pharma, Inc. | MEXER | 16,667 | — | — | +1.9% | Open the original filing on SEC.gov |
| Apr 1 | IGC | IGC Pharma, Inc. | MEXER | 323,077 | $0.26 | $84K | +7.5% | Open the original filing on SEC.gov |
| Apr 1 | IGC | IGC Pharma, Inc. | MEXER | 333,333 | — | — | +8.3% | Open the original filing on SEC.gov |